FMR LLC reports 13.8% stake in Prothena
FMR LLC reported beneficial ownership of common stock of Prothena Corporation plc.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC reported beneficial ownership of common stock of Prothena Corporation plc. FMR LLC held 7,199,218 shares, representing 13.8% of the outstanding common stock as of June 30, 2026, with sole power to dispose of all such shares and no shared voting or dispositive power.
Abigail P. Johnson is reported with sole dispositive power over the same 7,199,218 shares, but no sole or shared voting power. The filing notes that one or more other persons have rights to receive dividends or sale proceeds, including Fidelity Growth Company Commingled Pool, whose interest amounted to 3,335,877 shares, or 6.4% of Prothena’s common stock as of June 30, 2026.
Key Figures
Key Terms
beneficially owned financial
sole dispositive power financial
Schedule 13G regulatory
commingled pool financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Prothena (PRTA) does FMR LLC control?
What interest does Fidelity Growth Company Commingled Pool hold in Prothena (PRTA)?
Does any other party have rights to Prothena (PRTA) dividends or sale proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.